Company Profiles

driven by the PitchBook Platform

Amorphical

Description

Manufacturer of dietary pharmaceutical products. The company develops and manufactures dietary supplements and drugs for the treatment and prevention of human metabolic bone disease (MBD). It specializes in manufacturing a unique form of calcium called amorphous calcium carbonate (ACC). The company's R&D pipeline also includes clinical trials of ACC-based products for the treatment of osteoporosis, hypoparathyroidism, and cancer-related bone metastasis.

2004

Founded

PRIVATE

Status

Angel

Latest Deal Type

$1.2M

Latest Deal Amount

$1.2M

Total Amount Raised

Description

Manufacturer of dietary pharmaceutical products. The company develops and manufactures dietary supplements and drugs for the treatment and prevention of human metabolic bone disease (MBD). It specializes in manufacturing a unique form of calcium called amorphous calcium carbonate (ACC). The company's R&D pipeline also includes clinical trials of ACC-based products for the treatment of osteoporosis, hypoparathyroidism, and cancer-related bone metastasis.

Website:

www.amorphical.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Food Products
Pharmaceuticals

Primary Office

11 Haharash Street Ness-Ziona 7403118Israel +972 (0)8 699 5333
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Amorphical's full profile, request a free trial.

Amorphical Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Amorphical Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Yossi BenFounder & Chief Executive Officer
Yossi Ben Founder & Chief Executive Officer

Amorphical Board Members (1)

NameRepresentingRoleSinceContact
Info
Netta CohenSelfBoard Member000 0000
Netta Cohen Board Member Self
Request full access to PitchBook